Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia.

Standard

Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia. / Stams, Wendy A G; Boer, den; Monique, L; Holleman, Amy; Appel, Inge M; Beverloo, H Berna; Janka-Schaub, Gritta; Elisabeth, R; Janka-Schaub, Gritta E; Evans, William E; Pieters, Rob.

in: BLOOD, Jahrgang 105, Nr. 11, 11, 2005, S. 4223-4225.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Stams, WAG, Boer, D, Monique, L, Holleman, A, Appel, IM, Beverloo, HB, Janka-Schaub, G, Elisabeth, R, Janka-Schaub, GE, Evans, WE & Pieters, R 2005, 'Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia.', BLOOD, Jg. 105, Nr. 11, 11, S. 4223-4225. <http://www.ncbi.nlm.nih.gov/pubmed/15718422?dopt=Citation>

APA

Stams, W. A. G., Boer, D., Monique, L., Holleman, A., Appel, I. M., Beverloo, H. B., Janka-Schaub, G., Elisabeth, R., Janka-Schaub, G. E., Evans, W. E., & Pieters, R. (2005). Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia. BLOOD, 105(11), 4223-4225. [11]. http://www.ncbi.nlm.nih.gov/pubmed/15718422?dopt=Citation

Vancouver

Bibtex

@article{cd84ef1fe63a4c0c9a434130d408ac07,
title = "Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia.",
abstract = "Resistance to L-asparaginase in leukemic cells may be caused by an elevated cellular expression of asparagine synthetase (AS). Previously, we reported that high AS expression did not correlate to L-asparaginase resistance in TEL-AML1-positive B-lineage acute lymphoblastic leukemia (ALL). In the present study we confirmed this finding in TEL-AML1-positive patients (n = 28) using microarrays. In contrast, 35 L-asparaginase-resistant TEL-AML1-negative B-lineage ALL patients had a significant 3.5-fold higher AS expression than 43 sensitive patients (P <.001). Using real-time quantitative polymerase chain reaction (RTQ-PCR), this finding was confirmed in an independent group of 39 TEL-AML1-negative B-lineage ALL patients (P = .03). High expression of AS was associated with poor prognosis (4-year probability of disease-free survival [pDFS] 58% +/- 11%) compared with low expression (4-year pDFS 83% +/- 7%; P = .009). We conclude that resistance to l-asparaginase and relapse risk are associated with high expression of AS in TEL-AML1-negative but not TEL-AML1-positive B-lineage ALL.",
author = "Stams, {Wendy A G} and den Boer and L Monique and Amy Holleman and Appel, {Inge M} and Beverloo, {H Berna} and Gritta Janka-Schaub and R Elisabeth and Janka-Schaub, {Gritta E} and Evans, {William E} and Rob Pieters",
year = "2005",
language = "Deutsch",
volume = "105",
pages = "4223--4225",
journal = "BLOOD",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "11",

}

RIS

TY - JOUR

T1 - Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia.

AU - Stams, Wendy A G

AU - Boer, den

AU - Monique, L

AU - Holleman, Amy

AU - Appel, Inge M

AU - Beverloo, H Berna

AU - Janka-Schaub, Gritta

AU - Elisabeth, R

AU - Janka-Schaub, Gritta E

AU - Evans, William E

AU - Pieters, Rob

PY - 2005

Y1 - 2005

N2 - Resistance to L-asparaginase in leukemic cells may be caused by an elevated cellular expression of asparagine synthetase (AS). Previously, we reported that high AS expression did not correlate to L-asparaginase resistance in TEL-AML1-positive B-lineage acute lymphoblastic leukemia (ALL). In the present study we confirmed this finding in TEL-AML1-positive patients (n = 28) using microarrays. In contrast, 35 L-asparaginase-resistant TEL-AML1-negative B-lineage ALL patients had a significant 3.5-fold higher AS expression than 43 sensitive patients (P <.001). Using real-time quantitative polymerase chain reaction (RTQ-PCR), this finding was confirmed in an independent group of 39 TEL-AML1-negative B-lineage ALL patients (P = .03). High expression of AS was associated with poor prognosis (4-year probability of disease-free survival [pDFS] 58% +/- 11%) compared with low expression (4-year pDFS 83% +/- 7%; P = .009). We conclude that resistance to l-asparaginase and relapse risk are associated with high expression of AS in TEL-AML1-negative but not TEL-AML1-positive B-lineage ALL.

AB - Resistance to L-asparaginase in leukemic cells may be caused by an elevated cellular expression of asparagine synthetase (AS). Previously, we reported that high AS expression did not correlate to L-asparaginase resistance in TEL-AML1-positive B-lineage acute lymphoblastic leukemia (ALL). In the present study we confirmed this finding in TEL-AML1-positive patients (n = 28) using microarrays. In contrast, 35 L-asparaginase-resistant TEL-AML1-negative B-lineage ALL patients had a significant 3.5-fold higher AS expression than 43 sensitive patients (P <.001). Using real-time quantitative polymerase chain reaction (RTQ-PCR), this finding was confirmed in an independent group of 39 TEL-AML1-negative B-lineage ALL patients (P = .03). High expression of AS was associated with poor prognosis (4-year probability of disease-free survival [pDFS] 58% +/- 11%) compared with low expression (4-year pDFS 83% +/- 7%; P = .009). We conclude that resistance to l-asparaginase and relapse risk are associated with high expression of AS in TEL-AML1-negative but not TEL-AML1-positive B-lineage ALL.

M3 - SCORING: Zeitschriftenaufsatz

VL - 105

SP - 4223

EP - 4225

JO - BLOOD

JF - BLOOD

SN - 0006-4971

IS - 11

M1 - 11

ER -